Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066

Watchlist Manager
Shandong Weigao Group Medical Polymer Co Ltd Logo
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Watchlist
Price: 6.17 HKD 1.82% Market Closed
Market Cap: 28.2B HKD

Wall Street
Price Targets

Price Targets Summary
Shandong Weigao Group Medical Polymer Co Ltd

Wall Street analysts forecast Shandong Weigao Group Medical Polymer Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shandong Weigao Group Medical Polymer Co Ltd is 6.54 HKD with a low forecast of 5.25 HKD and a high forecast of 7.77 HKD.

Lowest
Price Target
5.25 HKD
15% Downside
Average
Price Target
6.54 HKD
6% Upside
Highest
Price Target
7.77 HKD
26% Upside
Shandong Weigao Group Medical Polymer Co Ltd Competitors:
Price Targets
300832
Shenzhen New Industries Biomedical Engineering Co Ltd
24% Upside
OSSD
OssDsign AB
4% Upside
OSUR
OraSure Technologies Inc
60% Upside
XVIVO
Xvivo Perfusion AB
59% Upside
CTEC
ConvaTec Group PLC
10% Upside
3593
Hogy Medical Co Ltd
12% Upside
301093
Jiangsu Hualan New Pharmaceutical Material Co Ltd
14% Upside
ICUI
ICU Medical Inc
45% Upside

Revenue
Forecast

Revenue Estimate
Shandong Weigao Group Medical Polymer Co Ltd

For the last 8 years the compound annual growth rate for Shandong Weigao Group Medical Polymer Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 7%.

11%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shandong Weigao Group Medical Polymer Co Ltd

For the last 8 years the compound annual growth rate for Shandong Weigao Group Medical Polymer Co Ltd's operating income is 9%. The projected CAGR for the next 3 years is 11%.

9%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Shandong Weigao Group Medical Polymer Co Ltd

For the last 8 years the compound annual growth rate for Shandong Weigao Group Medical Polymer Co Ltd's net income is 8%. The projected CAGR for the next 3 years is 10%.

8%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shandong Weigao Group Medical Polymer Co Ltd's stock price target?
Price Target
6.54 HKD

According to Wall Street analysts, the average 1-year price target for Shandong Weigao Group Medical Polymer Co Ltd is 6.54 HKD with a low forecast of 5.25 HKD and a high forecast of 7.77 HKD.

What is Shandong Weigao Group Medical Polymer Co Ltd's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Shandong Weigao Group Medical Polymer Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 7%.

What is Shandong Weigao Group Medical Polymer Co Ltd's Operating Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Shandong Weigao Group Medical Polymer Co Ltd's operating income is 9%. The projected CAGR for the next 3 years is 11%.

What is Shandong Weigao Group Medical Polymer Co Ltd's Net Income forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Shandong Weigao Group Medical Polymer Co Ltd's net income is 8%. The projected CAGR for the next 3 years is 10%.

Back to Top